Reproductive and Mental Health in Aplastic Anemia
Part of Blood & lymphatic clinical trials.
This study looks at how aplastic anemia affects reproductive and mental health in adults. By understanding these connections, doctors can provide better support for your overall well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with aplastic anemia (a condition where your bone marrow doesn't make enough blood cells).
- You are between 18 and 40 years old.
- You are willing and able to follow the study rules and sign a consent form.
- You do not have inherited bone marrow failure, other blood diseases, or a history of mental illness or reproductive system cancer.
- You are not pregnant, breastfeeding, or receiving chemotherapy that caused your bone marrow failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called CM313 for people with aplastic anemia that has not responded to standard treatments or has come back. The medicine is given as an injection under the skin and may help your bone marrow make more blood cells.
This study tests an experimental treatment made from special immune cells designed to help your body fight aplastic anemia. It may be an option if you still need blood transfusions despite standard treatments.
This study is testing whether a stem cell transplant (from a matched relative, unrelated donor, or half-matched donor) can help adults aged 40–60 with severe aplastic anemia that didn't get better or came back after standard treatments.
This study tests a medication called romiplostim, which helps the body make more blood cells, for children and young adults with severe aplastic anemia. It may help improve blood counts and reduce the need for transfusions.
This trial tests a new way of preparing adult patients with hard-to-treat aplastic anemia for a stem cell transplant. It uses a lower-intensity conditioning regimen (TMI) and umbilical cord blood, which may be safer and more effective for patients who have failed other treatments.
This trial studies using a donor's blood stem cells (from bone marrow or blood) for a transplant in people with severe aplastic anemia, a condition where the bone marrow stops making enough blood cells. The goal is to see if using a mix of both types of cells is better than just blood cells alone.
Hear when a new Aplastic Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.